Protara Therapeutics Inc Capital Reinvestment Ratio

Latest as of September 2023: 0.29x

Protara Therapeutics Inc capital reinvestment ratio. Protara Therapeutics Inc (TARA) has a Capital Reinvestment Ratio of 0.29x as of September 2023, meaning it reinvests 0% of its operating cash flow ($128.00K) in capital expenditures ($37.00K). Check TARA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.29x

Capex / Operating Cash Flow

Operating Cash Flow

$128.00K

USD

Capital Expenditures

$37.00K

USD

Data as of

Sep 2023

Most recent filing

Protara Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Protara Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Protara Therapeutics Inc cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow